H. Webster

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England

Katie Harman, J. Bridgen, Susan Hopkins, 2022, medRxiv.

Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England

A. Presanis, D. De Angelis, J. Bridgen, 2022, Nature Communications.

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

S. Bhatt, S. Flaxman, W. Hinsley, 2022, The Lancet.

Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021

V. Saliba, D. Chudasama, M. Ramsay, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England

S. Bhatt, S. Flaxman, W. Hinsley, 2022, SSRN Electronic Journal.

The impact of COVID‐19 on residents of long‐term care facilities with learning disabilities and/or autism

T. Lamagni, J. Flannagan, G. Dabrera, 2023, Influenza and other respiratory viruses.